170 results
Page 5 of 9
S-4/A
EX-10.6
71rllexapas4r
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-10.7
zjq0c6laiu54ai
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-10.3
kxnac1l1fti74w7fg oe
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-2.4
dd4v09irjokyrxf5
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.3
mte0 9qkblb99
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.2
tnniu 4ym
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-2.2
9dmuleeszty6oz320dys
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-2.3
luixdym
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-3.1
bbsvdqr hl5uv9j9
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-3.1
kv7sl1e3164
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.4
cvb ss60z1nln0hnv82
9 Aug 18
Business combination disclosure
5:17pm
425
EX-99.2
b6arb00vme4ez8qreb
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.3
hyslhxum
9 Aug 18
Business combination disclosure
5:17pm
425
EX-99.3
of0o373hff
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.2
u03i eq3wx
9 Aug 18
Business combination disclosure
5:17pm